Cigna Corporation(CI)
The Cigna Group provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care delivery and management, and intelligence solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, vision, health advocacy programs, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans to on and off the public exchanges; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. The company also offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. It distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.
Latest News & Analysis
Cigna's Strategic Overhaul: Claims, Mental Health, and Market Expansion in 2025
Explore Cigna’s 2025 transformation through claims simplification, youth mental health investments, and strategic partnerships.
Inside Cigna: Strategic Transformation & Market Impact
Cigna launches multi‐year initiatives from claims improvements to community investments, reshaping its healthcare strategy.
Cigna Group: Navigating Healthcare Trends and Strategic Developments in 2025
Cigna Group's latest updates showcase employee well-being, mental health initiatives, claims process improvements, and strategic partnerships impacting the healthcare industry.
Cigna's 2025 Strategy: Market Impact, Healthcare Trends, and Future Outlook
Discover how Cigna is transforming healthcare with integrated services, strategic partnerships, and innovative market initiatives.
Cigna Corporation: Strategic Initiatives, Financial Performance, and Future Outlook
Cigna Corporation strategically focuses on Evernorth's growth, stock buybacks, and navigating the evolving regulatory landscape, positioning it for long-term success.
Cigna's Strategic Overhaul: Divestitures, Partnerships, and Future Outlook
Cigna undergoes a strategic overhaul, divesting Medicare Advantage, expanding Evernorth, and navigating regulatory scrutiny, impacting investors and stakeholders.
Cigna Healthcare: Navigating Rising Medical Costs and Strategic Growth Initiatives
Cigna navigates rising medical costs while expanding medication access and emphasizing employee health. Regulatory scrutiny and industry trends pose challenges.
Cigna's Q4 2024: Navigating Rising Costs and Strategic Shifts
Cigna's Q4 2024 performance reveals strong revenue growth amidst rising medical costs. Strategic shifts, PBM challenges, and social responsibility initiatives shape its outlook.
Cigna Corporation: Navigating Healthcare Costs and Transformation
Cigna navigates rising healthcare costs with Evernorth, strategic divestitures, and digital transformation, focusing on long-term growth and shareholder value.
Cigna in 2025: Financial Outlook, Market Trends, and Strategic Initiatives
Cigna navigates healthcare challenges in 2025, balancing revenue growth with rising medical costs and strategic shifts. The company focuses on customer experience and mental health initiatives.
Cigna's Executive Shakeup: New CFO and Strategic Outlook
Leadership changes at Cigna signal strategic shifts. Ann Dennison appointed CFO, Brian Evanko as COO. Focus on growth, cost management, and customer experience.
Cigna's Strategic Shift: Medicare Sale and 2025 Financials
Cigna undergoes strategic realignment: Medicare sale, leadership changes, and 2025 outlook. Focus shifts to Evernorth and Cigna Healthcare amid rising costs.
Cigna (CI) Stock Analysis: Navigating Challenges and Opportunities
Analysis of Cigna's strategic shift with Medicare sale, leadership changes, and focus on cost management amidst market challenges and growth opportunities.
Cigna's Strategic Overhaul: Medicare Sale & Market Challenges
Cigna navigates strategic shifts with Medicare sale, leadership changes, and cost management, impacting investor confidence and market perception.
Cigna's Transformation: Financials, Strategy, and Market Impact
Cigna navigates healthcare shifts post-Medicare sale, focusing on Evernorth and Cigna Healthcare. Leadership changes and TMS coverage expansion signal strategic pivots.
Cigna (CI): Strategic Shift, Leadership, and Mental Health Focus
Cigna's strategic shift, leadership changes, and mental health expansion signal a focus on long-term value, but economic and regulatory challenges persist.
Cigna Faces PBM Probes Amidst Divergent 2024 Financials
Cigna faces PBM scrutiny in Canada and US, navigates divergent 2024 financials with revenue growth but net income decline, and pivots strategy.
Cigna's Strategic Pivot: Analyzing CI's GLP-1 Focus and Financials
An in-depth analysis of Cigna's recent strategic focus on GLP-1 coverage and Q1 2025 earnings, examining financial performance, regulatory impacts, and market positioning.
Cigna's Strategic Pivot: AI, Health Equity, and Drug Cost Innovation
Cigna's latest moves in AI, health equity, and drug cost management signal a robust strategic pivot, aiming to reshape healthcare delivery.
Cigna Corporation (CI) Stock Analysis: Uncovering Valuation Opportunities and Digital Innovation Strategies
Cigna Corporation ([CI](/dashboard/companies/CI)) shows a valuation discount despite robust revenue growth and AI-driven innovation. Analysis of financial health, digital transformation, and shareholder returns.
Cigna (CI) Analysis: Q2 Earnings, Evernorth Growth, Strategic Shifts
Deep dive into Cigna's financial performance, Q2 earnings, Evernorth growth, AI strategies, drug pricing, antitrust litigation, and valuation.
Cigna (CI) Financial Analysis: Revenue Soars, Profits Decline
Cigna's 2024 revenue surged +25.21% to $244.38B, yet net income fell -33.5%. This analysis dives into the diverging performance and strategic implications.
Cigna Corporation Latest Developments: Growth Strategy, Financial Health, and Market Position Analysis
Explore Cigna Corporation's strategic growth initiatives, financial performance, and market positioning, highlighting recent coverage expansions and earnings outlook.
Cigna Corporation (CI) Latest Strategic Initiatives and Financial Performance Analysis
Explore Cigna Corporation's recent strategic moves, financial metrics, and market positioning shaping its growth trajectory in health services.
Cigna Corporation (CI) Strategic Update: Leveraging Evernorth Growth Amid Healthcare Sector Challenges
Cigna's latest strategic moves focus on Evernorth's expansion and commercial insurance growth amidst sector turmoil, with key financial insights and competitive positioning.
Cigna Corporation: Strategic Shift to GLP-1 Market Fuels Growth and Enhances Investor Value
Cigna's strategic pivot from Medicare Advantage to GLP-1 leadership, backed by Evernorth's innovations, drives growth, margin improvement, and shareholder returns.
Cigna Corporation (CI) GLP-1 Strategy Fuels Specialty Pharmacy Growth and Investor Value
Cigna's targeted GLP-1 management via Evernorth drives revenue growth, cost control, and sustainable dividends amid evolving healthcare market dynamics.
Cigna Corporation's GLP-1 Strategy and Q2 2025 Earnings: A Deep Dive into Financial Impact and Market Position
Cigna's strategic GLP-1 initiatives, Evernorth's copay cap, and Q2 2025 earnings preview highlight its leadership in managed care and financial resilience.
Cigna Corporation Q2 2025 Analysis: Evernorth Growth Drives Resilience Amid Healthcare Cost Challenges
Cigna's Q2 2025 earnings reveal Evernorth's pivotal role in revenue growth, strategic AI investments, and effective cost management amid rising healthcare expenses.
Cigna Corporation (CI) Latest Financial and Strategic Analysis - Market Insights 2025
Explore Cigna Corporation's recent financial performance, strategic moves, and market positioning with data-driven insights for investors in 2025.
Cigna Corporation (CI): Revenue Surge, Profit Shock and the Free-Cash-Flow Cushion
Cigna posted **$247.12B** revenue in FY2024 (+26.55%) while net income fell to **$3.43B** (-33.53%). Strong FCF and Evernorth growth clash with margin pressure and sector risk.
Cigna (CI) Analysis: Strategic Shifts Amidst Mixed Financials
Cigna's recent strategic moves, including health equity grants and expanded drug coverage, unfold alongside robust revenue growth but declining net income.
Cigna Corporation: Shields Bet and the Margin Trade-Off in 2025
Cigna's $3.5B Shields investment accelerates Evernorth's specialty push even as FY2024 shows revenue +26.56% and net income -33.50%, raising stakes for margin recovery.
Cigna (CI): Revenue Surge Masks Profit Compression as $3.5B Shields Bet Reshapes Evernorth
Cigna posted **$247.12B revenue (+26.56% YoY)** in 2024 while **net income fell to $3.43B (-33.50%)**; Evernorth’s **$3.5B** Shields investment is a strategic pivot to specialty pharmacy.